Catello Califano Selected Research

Catello Califano Research Topics

Disease

9	Multiple Myeloma 11/2023 - 10/2009
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2024 - 08/2006
3	Lymphoma (Lymphomas) 02/2024 - 01/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024 - 06/2005
2	Hodgkin Disease (Hodgkin's Disease) 10/2021 - 01/2013
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 12/2016
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2021 - 01/2018
2	Hemolysis 12/2010 - 07/2007
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2010 - 08/2006
2	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 07/2007 - 08/2006
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 02/2024
1	Amyloidosis 11/2023
1	Body Weight (Weight, Body) 11/2023
1	Renal Insufficiency (Renal Failure) 11/2023
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2023
1	Infections 01/2023
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023
1	Septic Shock (Toxic Shock Syndrome) 01/2023
1	Thrombosis (Thrombus) 05/2021
1	Leukemia 05/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 05/2021
1	Philadelphia Chromosome 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2018
1	Thrombocytopenia (Thrombopenia) 12/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 05/2010
1	Amyloid Plaque 05/2010
1	Pathologic Complete Response 07/2007
1	Chronic Disease (Chronic Diseases) 07/2007
1	Osteonecrosis (Kienbock's Disease) 06/2007
1	Sepsis (Septicemia) 08/2006
1	Heart Failure 08/2006

Drug/Important Bio-Agent (IBA)

4	Rituximab (Mabthera)FDA Link 02/2024 - 08/2006
4	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 07/2012
4	Lenalidomide (CC 5013)FDA Link 01/2023 - 01/2018
3	Monoclonal AntibodiesIBA 11/2023 - 08/2006
3	Bendamustine Hydrochloride FDA Link 10/2023 - 01/2013
3	elotuzumabIBA 01/2023 - 01/2021
3	Bortezomib (Velcade)FDA Link 01/2018 - 05/2010
2	ibrutinibIBA 03/2024 - 01/2018
2	SteroidsIBA 01/2021 - 08/2006
2	Thalidomide (Thalomid)FDA Link 07/2012 - 10/2009
2	fludarabineIBA 12/2010 - 06/2005
1	Gemtuzumab (Mylotarg)FDA Link 04/2024
1	Chlorambucil (Leukeran)FDA Link 02/2024
1	insulin receptor-related receptor (IRR)IBA 11/2023
1	daratumumabIBA 11/2023
1	Proteasome InhibitorsIBA 01/2023
1	posaconazole FDA Link 01/2023
1	pomalidomideIBA 01/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	EchinocandinsIBA 01/2023
1	luspaterceptIBA 01/2023
1	belantamab mafodotinIBA 01/2022
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2021
1	Dasatinib (BMS 354825)FDA Link 01/2021
1	PanobinostatIBA 12/2018
1	SuspensionsIBA 12/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	temsirolimus FDA Link 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 12/2016
1	Amyloid (Amyloid Fibrils)IBA 05/2010
1	Congo RedIBA 05/2010
1	Hemoglobins (Hemoglobin)IBA 05/2010
1	beta 2-Microglobulin (beta 2 Microglobulin)IBA 05/2010
1	Immunoglobulins (Immunoglobulin)IBA 05/2010
1	CalciumIBA 05/2010
1	CreatinineIBA 05/2010
1	Antineoplastic Agents (Antineoplastics)IBA 05/2010
1	AlbuminsIBA 05/2010
1	AutoantibodiesIBA 07/2007
1	Diphosphonates (Bisphosphonates)IBA 06/2007
1	TransferasesIBA 08/2006
1	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2005

Therapy/Procedure

6	Therapeutics 01/2023 - 08/2006
4	Drug Therapy (Chemotherapy) 04/2024 - 12/2016
2	Stem Cell Transplantation 01/2013 - 10/2009
1	Catheters 05/2021
1	Salvage Therapy 01/2021
1	Homologous Transplantation 01/2021
1	Drug Tapering 12/2018
1	Immunotherapy 01/2018
1	Hematopoietic Stem Cell Transplantation 07/2012
1	Aftercare (After-Treatment) 05/2010
1	Autologous Transplantation 10/2009